Asim Kichloo, Michael Albosta, Kirk Dettloff, Farah Wani, Zain El-Amir, Jagmeet Singh, Michael Aljadah, Raja Chandra Chakinala, Ashok Kumar Kanugula, Shantanu Solanki, Savneek Chugh
A narrative review was conducted to examine the current state of the utilisation of telemedicine amid the current COVID-19 pandemic and to evaluate the benefits of continuing telemedicine usage in the future. A literature review was performed for articles related to telemedicine. Databases including PubMed, Google Scholar, Cochrane Library and Ovid MEDLINE were searched. Three reviewers independently performed article selection based on relevance to our topic. We included all articles between 1990 and 2020 related to telemedicine using the following keywords: 'telemedicine', 'telehealth', 'policy', 'COVID-19', 'regulation', 'rural', 'physical examination', 'future'. A total of 60 articles were identified, and through careful selection we narrowed the final number of articles to 42 based on relevance to our topic. Telemedicine has been rapidly evolving over the past several decades. Issues with regulation and reimbursement have prevented its full immersion into the healthcare system. During the current pandemic, Centers for Medicare and Medicaid services have expanded access to telemedicine services. The advantages of telemedicine moving forward include its cost-effectiveness, ability to extend access to specialty services and its potential to help mitigate the looming physician shortage. Disadvantages include lack of available technological resources in certain parts of the country, issues with security of patient data, and challenges in performing the traditional patient examination. It is critically important that changes are made to fully immerse telemedicine services into the healthcare landscape in order to be prepared for future pandemics as well as to reap the benefits of this service in the future.
Stroke. 2017 Jan;48(1):e3-e25
[PMID:
27811332]
J Telemed Telecare. 2018 Jan;24(1):4-12
[PMID:
29320966]
J Pain Symptom Manage. 2020 Jul;60(1):e12-e14
[PMID:
32240756]
J Med Syst. 2016 Jun;40(6):145
[PMID:
27118011]
JAMA Intern Med. 2015 Dec;175(12):1983-6
[PMID:
26437386]
J Allergy Clin Immunol Pract. 2020 May;8(5):1489-1491
[PMID:
32220575]
Ann Fam Med. 2017 May;15(3):225-229
[PMID:
28483887]
Am J Emerg Med. 2019 May;37(5):890-894
[PMID:
30100333]
N Engl J Med. 2016 Jul 14;375(2):154-61
[PMID:
27410924]
Healthc Financ Manage. 2000 Apr;54(4):66-9
[PMID:
10915354]
N Engl J Med. 2020 Apr 30;382(18):1679-1681
[PMID:
32160451]
Healthc Inform Res. 2015 Oct;21(4):239-43
[PMID:
26618029]
J Am Med Inform Assoc. 2015 Apr;22(e1):e28-33
[PMID:
25147247]
Bull Med Libr Assoc. 1996 Jan;84(1):71-9
[PMID:
8938332]
Curr Allergy Asthma Rep. 2018 Aug 25;18(10):54
[PMID:
30145709]
J Visc Surg. 2016 Aug;153(4):249-52
[PMID:
27423211]
NCHS Data Brief. 2014 May;(151):1-8
[PMID:
24813076]
Ann Med Surg (Lond). 2017 Jul 18;21:58-62
[PMID:
28794868]
Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098
[PMID:
26343551]
N Engl J Med. 2020 Jun 4;382(23):e82
[PMID:
32240581]
Schizophr Res. 2020 Jun 15;:
[PMID:
32553433]
J Telemed Telecare. 2020 Jun;26(5):309-313
[PMID:
32196391]
BMJ. 2020 Mar 12;368:m998
[PMID:
32165352]
Appl Clin Inform. 2015 Jan 14;6(1):16-26
[PMID:
25848410]
J Telemed Telecare. 2019 Nov 6;:1357633X19878330
[PMID:
31690169]